9 citations
,
January 2014 in “Postepy Dermatologii I Alergologii” This study evaluated the Polish version of Skindex-29, demonstrating its reliability and validity as a tool to measure quality of life in dermatology patients.
November 2024 in “Skin Appendage Disorders” In this study, researchers assessed the quality of life in patients with different types of alopecia using the Skindex-29 and DLQI questionnaires, finding that telogen effluvium and alopecia areata had the greatest pretreatment impact on quality of life, with moderate responsiveness observed after treatment.
February 2022 in “Pakistan Armed Forces Medical Journal” This study concluded that androgenetic alopecia more severely impacts the quality of life of females compared to males among Pakistani patients, as measured by Skindex-29 scores.
April 2016 in “Journal of The American Academy of Dermatology” This study found that patients with androgenetic alopecia reported worse symptom-related quality of life scores than those with alopecia areata, particularly influenced by age of onset, disease duration, and severity.
4 citations
,
August 2019 in “Actas Dermo-Sifiliográficas” This study evaluated the Spanish version of the Hair Specific Skindex-29 questionnaire and found it sensitive to changes in health-related quality of life among women with female-pattern hair loss.
